Exercise for Perimenopause. Built Around Your Biology.

Reviewed by Dr. Marissa Baranauskas, PhD, Exercise Physiologist, University of Colorado Colorado SpringsLast updated: April 19, 2026

You used to crush workouts. Now the same routine wrecks you for three days, you're gaining weight on less food, and every app you've tried keeps telling you to push harder.

"struggling ALOT with the loss of fitness due to the perimenopause"

Voiced in r/Perimenopause community discussions, 2026

Perimenopause changes how your body responds to training. Most of what's on the market hasn't gotten the memo.

What other apps get wrong about perimenopause

They program women as small men.

Most training protocols were built and tested on young men. Sports science has run roughly two-thirds male participants for decades, and the prescriptions that came out of it got handed to women with the numbers scaled down and nothing else changed. That's not a small oversight it means the volume, the recovery intervals and the progression rates you've been given were calibrated on bodies that recover differently from yours.

Streak counters punish the days your body needs off.

Missing a session in perimenopause isn't failure. Gamification borrowed from men's training apps trains you to override the signal that used to tell you to rest and then makes you feel like you've broken something when you listen to it.

"the last few months it's been 2 weeks of disruption which really messes up a training plan so I quit"
— voiced in r/Perimenopause community discussions, 2026

That's the whole problem in one sentence. Not intensity. Not modality. Two weeks of disruption and a plan with no way to absorb it.

Cycle-syncing never worked, and now there's no cycle to sync to.

Calendar-phase programming was already built on weak ground the best evidence says cycle phase doesn't reliably change strength performance or adaptation for anyone. In perimenopause it stops even being possible. Your cycle shortens, then lengthens, then skips. There's nothing left for a calendar to predict.

How Salerna programs for perimenopause

1. Strength first, and heavier than you've been told.

Bone loss accelerates through the menopause transition, and the response is progressive loading, not caution. In the LIFTMOR trial, 101 postmenopausal women with osteopenia or osteoporosis (mean age 65) did supervised high-intensity resistance and impact training — deadlift, overhead press and back squat at over 85% of one-rep max, plus jumping chin-ups — twice weekly for eight months. Lumbar spine bone density rose 2.9% against a 1.2% loss in controls, with one minor adverse event across more than 2,600 sessions (Watson et al., 2018).

Two honest notes on that trial: every session was supervised by an exercise scientist and a physiotherapist, and the participants were postmenopausal rather than perimenopausal. It's the best evidence in this area and it isn't a perfect match for you. We build toward loads you can actually progress, and we tell you where the evidence came from.

2. Intensity capped by recovery, not by fear.

Cardiovascular risk climbs sharply through the transition (American Heart Association scientific statement, 2020), so dropping intensity is the wrong instinct. High-intensity work has real benefit and you should be doing some.

What changes is how much you can absorb. We extend your warm-up and cool-down, lengthen rest between exercises, and pull high-intensity work entirely on days you report hot flashes. We don't cut your volume or your loads, because the evidence doesn't support training you lighter, it supports giving you more room around the work.

3. Joints get more say than they used to.

Declining estrogen reduces collagen synthesis and slows tendon adaptation (Chidi-Ogbolu and Baar, 2019). That's a well-supported finding and it's why we treat an irritable knee or shoulder as programming information rather than something to push through.

4. A daily check-in, not a fixed calendar.

Four questions before every session: sleep, energy, soreness, stress. A poor-recovery day changes the session. It doesn't trigger a notification telling you to show up anyway.

You train what your body can do today, not what the plan said last Monday. That's the whole design, and it exists because the thing that ends most training plans in perimenopause isn't the training — it's two bad weeks with no way to bend.

"I am also prone to over training with too much intensity"
— voiced in r/Perimenopause community discussions, 2026

5. Clinician-reviewed rules, and you can see them.

Our advisory board reviews the condition logic and holds the authority to switch a rule off. When your session changes, you can see which input changed it.

Frequently Asked Questions

  • It's more common than most women are told. In the SWAN cohort of over 3,000 midlife women, about half reported palpitations at a moderate or high rate, peaking during perimenopause and early postmenopause and easing later (Carpenter et al., 2023). Reassuringly, in that same study palpitation patterns were not linked to atherosclerosis or arterial stiffness.

    What we won't tell you is that it's definitely your hormones. Three things cause exactly this picture in your forties and all three are cheap to check: thyroid function, iron levels (heavy perimenopausal bleeding is a common and frequently missed cause of iron deficiency), and less often a rhythm issue. The European Menopause and Andropause Society specifically advises clinicians to keep a low threshold for thyroid testing in midlife women, because the symptoms overlap almost completely with the transition. If this is new and it's persisted for weeks, get it looked at before you assume it's training or hormones.

    Salerna's perimenopause programming adds a longer warm-up and cool-down and more rest between exercises, and it doesn't cut your loads or your volume to do it. That's a recovery-capacity decision, and you can see it in your session notes.

    ‍ Sources:Carpenter 2023, SWAN palpitations, Menopause · Carpenter 2021 prevalence review · EMAS 2024 thyroid & menopause position statement · Harlow 2025, SWAN, abnormal uterine bleeding & fatigue

  • No. If anything the instinct to back off is the wrong one. Cardiovascular risk climbs through the menopause transition, which is an argument for keeping hard work in, not taking it out (American Heart Association scientific statement, El Khoudary et al., 2020). That statement sets a floor for vigorous activity which is 75 minutes a week, or 150 minutes of moderate work with no ceiling. It also found that only about 7% of midlife women in the SWAN cohort consistently met it. The realistic problem is almost never too much intensity.

    What we do change is what surrounds it. Salerna's perimenopause programming adds roughly a minute to your warm-up and your cool-down and thirty seconds to rest between exercises without reducing your loads or your volume, because the evidence doesn't support training you lighter. And on a day you report hot flashes, high-intensity work comes out of that session entirely.

    Two honest notes. You choose how many days a week you train, so how the hard efforts get spent across those days, intervals against heavy lifting, is a real trade-off, and it's a general training principle rather than a menopause finding. And nobody has run the trial that says how much HIIT a perimenopausal woman should do. We'll tell you when someone does.

    ‍ ‍Sources:El Khoudary 2020, AHA scientific statement, Circulation · Physical Activity Guidelines for Americans, 2nd ed.

  • You decide that one, and here's what you need to decide it well.

    Two days a week is the floor. The US Physical Activity Guidelines ask adults for muscle-strengthening work on two or more days. For bone specifically, the research points a little higher: meta-analyses of resistance training in postmenopausal women find the clearest bone results at three sessions a week at 70% of your one-rep max or above, sustained for about a year (Wang et al., 2023; and a 2025 review of 17 trials). The NSCA's older-adult position statement , whose evidence base starts at 50 and leans toward 65-plus, recommends 70–85% of 1RM, two to three times a week, on non-consecutive days (Fragala et al., 2019).

    But the number that matters in all of that isn't the frequency. It's the load, and the fact that it has to be sustained for months. Two well-loaded sessions beat four easy ones, and three days you'll actually keep beats five you'll abandon in March.

    Salerna doesn't pick your days, you do. You tell us how many days a week you want to train, what equipment you have, your life stage and any conditions. The engine programs into that. What we take responsibility for is what goes in those sessions: how the work is distributed, how load progresses, and what changes when your check-in says today isn't the day. Pick the number you can hold. We'll make it count.

    ‍ ‍Sources:PAG 2nd ed. · Fragala 2019, NSCA position statement, JSCR · Wang 2023, Front Physiol network meta-analysis · J Orthop Surg Res 2025, optimal RT parameters for BMD

  • Probably not directly.
    The Cochrane review of five trials concluded there was insufficient evidence to show whether exercise treats vasomotor symptoms. It’s not that it fails, but that the studies weren't good enough to say (Daley et al., 2014). The largest analysis since (21 trials, 2,884 women) found no effect on hot flash frequency and only a small effect on severity, at very low certainty, which shrank by more than half once the poorer-quality trials were excluded (Liu et al., 2022). The Menopause Society's 2023 nonhormone position statement lists exercise among treatments not recommended for vasomotor symptoms. NICE doesn't recommend it for hot flashes either. Two guideline bodies, same conclusion.

    What exercise does reliably do in the menopause transition: depression and anxiety symptoms improve meaningfully across 21 randomised trials (Yue et al., 2025), and if your sleep is already disturbed, exercise measurably improves it. Though in women whose sleep is fine, it doesn't change much (Yu et al., 2023). Add bone, cardiovascular risk, and strength. That's a real list. Hot flashes just aren't on it.

    Talk to your clinician about vasomotor symptoms specifically. There are treatments with strong evidence, and we're not one of them.

    ‍ ‍Sources:Daley 2014, Cochrane CD006108 · Liu 2022, Climacteric · The Menopause Society 2023 nonhormone position statement, Menopause · Berin 2019, Maturitas · Spetz Holm 2024, 2-year follow-up, BMC Womens Health · Yue 2025, IJBNPA · Yu 2023, Front Med

  • Safe, and the direction of the evidence is the opposite of what you've been told. In the LIFTMOR trial, 101 postmenopausal women with osteopenia or osteoporosis (mean age 65) trained twice a week for eight months — deadlift, back squat and overhead press at over 85% of one-rep max, plus jumping chin-ups. Lumbar spine bone density rose 2.9% while the control group lost 1.2%. Across more than 2,600 training sessions there was one minor adverse event (Watson et al., 2018).

    There a three things that you should be aware of. The study looked at postmenopausal women older than you probably are. The protocol included impact work, not just lifting, so the bone result belongs to both. And every session was supervised by an exercise scientist and a physiotherapist at eight participants to one instructor; the authors explicitly advise against running their protocol unsupervised. It's the best evidence in this area and it isn't a perfect match for you.

    What that means for how we program: we build toward loads you can genuinely progress rather than dropping you into a research protocol, we progress gradually, and we screen movement selection against the joint symptoms you report. When your session changes, you can see which input changed it.

    If you have diagnosed low bone density, or any pelvic floor symptom, get eyes on your technique. Either a pelvic health physiotherapist or a coach in the room. An app should not be the only thing watching you lift heavy.

    ‍ ‍Sources:Watson 2018, LIFTMOR, JBMR · Watson 2019, Osteoporos Int — vertebral fracture safety follow-up

  • Because the scale is measuring the wrong thing. In SWAN body weight climbed at the same steady rate before and through the transition. It didn't accelerate. What accelerated was composition: fat gain roughly doubled, from about 1% a year to 1.7%, and lean mass flipped from slowly gaining to slowly losing. The shift starts about two years before the final period and settles about eighteen months after. That’s roughly a three-and-a-half-year window (Greendale et al., 2019).

    At the same time the fat you have redistributes toward the abdomen. Visceral fat can go from around 5–8% of total body fat before menopause to 15–20% after, driven partly by declining estrogen and changing insulin sensitivity and it happens independently of whether your weight changes at all (Kapoor et al., 2017, review; American Heart Association scientific statement, 2020).

    What actually works, split honestly. For the visceral fat and the waist measurement specifically, aerobic work does more than lifting — across 101 trials in postmenopausal women, aerobic training moved fat mass and waist circumference where resistance training didn't reliably. What resistance training does, and nothing else does as well, is build and hold the lean mass the transition erodes. Combined training beats either alone. That's why we prescribe both.

    On protein: most expert guidance for adults strength-training in midlife lands around 1.2–1.6 g per kg of body weight per day. Be aware that's expert consensus extrapolated from general adult research. The official RDA is 0.8 g/kg, and the trials testing higher intakes specifically in postmenopausal women are few and mixed. It’s worth a conversation with your clinician or a dietitian, not a rule we'll enforce.

    Salerna biases your program toward muscle retention and tracks strength progression as the primary outcome, not scale weight.

    ‍ ‍Sources:Greendale 2019, SWAN, JCI Insight · Kapoor 2017, Mayo Clin Proc · El Khoudary 2020, AHA, Circulation · Front Endocrinol 2023, exercise & body composition in postmenopausal women, 101 RCTs · Bauer 2013, PROT-AGE, JAMDA

  • Cycle-syncing was built on shaky ground before your cycle ever changed. The best available evidence, including a meta-analysis of the whole literature and a 2025 study measuring muscle protein synthesis directly, has not found that cycle phase reliably drives strength performance or training adaptation in anyone (McNulty et al., 2020; Colenso-Semple et al., 2025). Calendar-phase programming asks a question the research hasn't answered for regular cycles, and in perimenopause there's no longer a calendar to ask it of.

    Salerna uses a symptom-responsive model instead. You check in each day and the session responds to those inputs plus your wearable data. The engine runs the same way whether you cycle every 24 days, every 40, or haven't had a period in three months, because it was never reading the calendar in the first place.

    ‍ ‍Sources:McNulty 2020, Sports Med · Colenso-Semple et al. 2025, J Physiol — [VERIFY exact citation/DOI before publishing]. n=12, null result. Frame as "found no difference," never "proved no difference."

  • Short answer: for most healthy women, yes, with four caveats you should be aware of. Longer answer: the evidence is better than most supplements and thinner than the marketing suggests.

    What's actually established. Pooling seven trials in 608 postmenopausal women, creatine monohydrate produced small additive gains — about 0.37 kg of lean mass and meaningfully better leg strength — and only when taken alongside resistance training. The dose associated with benefit was 5 g a day or more; lower doses without training did nothing. It did not improve bone density, and the largest trial (two years, 237 women) found no bone effect at all.

    The four safety caveats. Talk to your clinician first if you have kidney disease or reduced kidney function. Tell your provider you're taking it before bloodwork: creatine raises measured blood creatinine, which can look like reduced kidney function on a lab report when nothing is wrong.
    And choose a product that's third-party tested, NSF Certified for Sport or Informed Choice, because supplements aren't reviewed by the FDA before they're sold.

    Creatine sits outside the Salerna programming engine. We don't prescribe supplements. We flag it as one of the better-supported options to discuss with your clinician, and we'd rather give you the caveats than the pitch. Our supplements guide has the full breakdown.

    ‍ ‍Sources:Naddafha 2026, JISSN — meta-analysis in postmenopausal women · Smith-Ryan 2021, Nutrients — creatine in women's health · Chilibeck 2023, MSSE — 2-year bone RCT · Xu 2024, Front Nutr — cognition meta-analysis and Citherlet 2026 commentary · Korovljev 2026, CONCRET-MENOPA · Kreider 2017, ISSN position stand · Kabiri Naeini 2025, BMC Nephrol — creatine and kidney markers

Ready to train the body that’s actually changing?

Join the Beta. Full programming, full adaptation, no credit card traps at the end.

Start training perimenopause